EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study

Qixia Luo, Linna Xu, Yuan Wang, Hao Fu, Tingting Xiao, Wei Yu, Wangxiao Zhou, Kanghui Zhang, Jiaying Shen, Jinru Ji, Chaoqun Ying, Yonghong Xiao

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.01.014 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Qixia Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Di…. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Klebsiella Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Health Commission of the People's Republic of China, Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To study the clinical relevance, mechanisms, and evolution of polymyxin B (POLB) heteroresistance (PHR) in carbapenem-resistant Klebsiella pneumoniae (CRKP), potentially leading to a significant rise in POLB full resistant (FR) CRKP. METHODS: Total of 544 CRKP isolates from 154 patients treated with POLB were categorized into PHR and POLB non-heteroresistance (NHR) groups. We performed statistical analysis to compare clinical implications and treatment responses. We employed whole-genome sequencing, bioinformatics, and PCR to study the molecular epidemiology, mechanisms behind PHR, and its evolution into FR. RESULTS: We observed a considerable proportion (118 of 154, 76.62%) of clinically undetected PHR strains before POLB exposure, with a significant subset of them (33 of 118, 27.97%) evolving into FR after POLB treatment. We investigated the clinical implications, epidemiological characteristics, mechanisms, and evolutionary patterns of PHR strains in the context of POLB treatment. About 92.86% (39 of 42) of patients had PHR isolates before FR, highlighting the clinical importance of PHR. the ST15 exhibited a notably lower PHR rate (1 of 8, 12.5% vs. 117 of 144, 81.25%; p < 0.01). The ST11 PHR strains showing significantly higher rate of mgrB mutations by endogenous insertion sequences in their resistant subpopulation (RS) compared with other STs (78 of 106, 73.58% vs. 4 of 12, 33.33%; p < 0.01). The mgrB insertional inactivation rate was lower in FR isolates than in the RS of PHR isolates (15 of 42, 35.71% vs. 84 of 112, 75%; p < 0.01), whereas the pmrAB mutation rate was higher in FR isolates than in the RS of PHR isolates (8 of 42, 19.05% vs. 2 of 112, 1.79%; p < 0.01). The evolution from PHR to FR was influenced by subpopulation dynamics and genetic adaptability because of hypermutability. DISCUSSION: We highlight significant genetic changes as the primary driver of PHR to FR in CRKP, underscoring polymyxin complexity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsHumansPolymyxinsPolymyxin BClinical RelevanceKlebsiella pneumoniaeRetrospective StudiesGenomicsCarbapenemsAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Carbapenem resistanceClinical relevanceEvolutionKlebsiella pneumoniaePolymyxin B heteroresistance

Substanzen

PolymyxinsPolymyxin BCarbapenemsAnti-Bacterial Agents

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of M…

Förderung

  • National Natural Science Foundation of China
  • National Health Commission of the People's Republic of China
  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Luo, Q., Xu, L., Wang, Y., Fu, H., Xiao, T., Yu, W., Zhou, W., Zhang, K., Shen, J., Ji, J., Ying, C., & Xiao, Y. (2024). Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.01.014

Vancouver

Luo Q, Xu L, Wang Y, Fu H, Xiao T, Yu W, et al. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.01.014

BibTeX
@article{Luo2024,
  author = {Luo, Qixia and Xu, Linna and Wang, Yuan and Fu, Hao and Xiao, Tingting and Yu, Wei and Zhou, Wangxiao and Zhang, Kanghui and Shen, Jiaying and Ji, Jinru and Ying, Chaoqun and Xiao, Yonghong},
  title = {Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.01.014}
}
Kostenlos starten →